Ubiquitin and Parkinson's disease through the looking glass of genetics
暂无分享,去创建一个
[1] S. Dunnett,et al. Phosphorylation of Parkin at serine 65 is essential for its activation in vivo , 2018, Royal Society Open Biology.
[2] F. Facchin,et al. Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson’s Disease Data , 2018, Genes.
[3] H. Laman,et al. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease. , 2017, Current protein & peptide science.
[4] M. Farrer,et al. Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism , 2016, Brain : a journal of neurology.
[5] T. Wai,et al. The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i‐AAA protease YME1L , 2016, EMBO reports.
[6] M. Lazarou,et al. Deciphering the Molecular Signals of PINK1/Parkin Mitophagy. , 2016, Trends in cell biology.
[7] A. Mrejeru,et al. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation , 2016, Stem cell reports.
[8] J. Schulz,et al. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice , 2016, The EMBO journal.
[9] M. Glickman,et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome , 2016, Cell.
[10] D. Komander,et al. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease , 2016, The Biochemical journal.
[11] Michael J. Munson,et al. mito-QC illuminates mitophagy and mitochondrial architecture in vivo , 2016, The Journal of cell biology.
[12] J. Troncoso,et al. Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. , 2016, The Journal of clinical investigation.
[13] H. McBride,et al. Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system , 2016, The Journal of cell biology.
[14] A. Goldberg,et al. Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease , 2016, Proceedings of the National Academy of Sciences.
[15] H. McBride,et al. Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation , 2016, Cell.
[16] Kay Hofmann,et al. MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes , 2016, Molecular cell.
[17] Y. Ye,et al. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells , 2016, Nature Cell Biology.
[18] N. Hattori,et al. Absence of Lewy pathology associated with PINK1 homozygous mutation , 2016, Neurology.
[19] Cong Han,et al. Probes of ubiquitin E3 ligases enable systematic dissection of parkin activation. , 2016, Nature chemical biology.
[20] A. Dillin,et al. Walking the tightrope: proteostasis and neurodegenerative disease , 2016, Journal of neurochemistry.
[21] Andrew B Singleton,et al. Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance , 2016, Journal of neurochemistry.
[22] N. Hattori,et al. FBXO7 mutations in Parkinson's disease and multiple system atrophy , 2016, Neurobiology of Aging.
[23] H. Walden,et al. Specificity and disease in the ubiquitin system , 2016, Biochemical Society transactions.
[24] H. Lashuel,et al. Semisynthesis and Enzymatic Preparation of Post-translationally Modified α-Synuclein. , 2016, Methods in molecular biology.
[25] V. Hristova,et al. Identification of a Novel Zn 2 !-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E 3 Ligase Parkin * , 2016 .
[26] P. Fraser,et al. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization* , 2015, The Journal of Biological Chemistry.
[27] Y. Yoo,et al. Measuring In Vivo Mitophagy. , 2015, Molecular cell.
[28] J. Corvol,et al. Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1 , 2015, The EMBO journal.
[29] J. Harper,et al. The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy. , 2015, Molecular cell.
[30] Elisabeth L. Moussaud-Lamodière,et al. (Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation , 2015, EMBO reports.
[31] J. Burman,et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy , 2015, Nature.
[32] P. Mercier,et al. Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis , 2015, The EMBO journal.
[33] Jimin Wang,et al. A Ubl/ubiquitin switch in the activation of Parkin , 2015, The EMBO journal.
[34] D. Komander,et al. Mechanism of phospho-ubiquitin induced PARKIN activation , 2015, Nature.
[35] H. Laman,et al. Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression , 2015, The Journal of pathology.
[36] A. Leutenegger,et al. A new F‐box protein 7 gene mutation causing typical Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[37] A. Prescott,et al. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation , 2015, EMBO reports.
[38] J Wade Harper,et al. Quantifying ubiquitin signaling. , 2015, Molecular cell.
[39] J. Harper,et al. Loss of neuronal Miro1 disrupts mitophagy and induces hyperactivation of the integrated stress response , 2015, Proceedings of the National Academy of Sciences.
[40] K. Lim,et al. Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling* , 2015, The Journal of Biological Chemistry.
[41] D. Dickson,et al. Defining neurodegeneration on Guam by targeted genomic sequencing , 2015, Annals of neurology.
[42] X. Zhuang,et al. A53T Human α-Synuclein Overexpression in Transgenic Mice Induces Pervasive Mitochondria Macroautophagy Defects Preceding Dopamine Neuron Degeneration , 2015, The Journal of Neuroscience.
[43] R. Youle,et al. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.
[44] B. Monsarrat,et al. Deciphering preferential interactions within supramolecular protein complexes: the proteasome case , 2015, Molecular systems biology.
[45] David Komander,et al. Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis , 2014, The EMBO journal.
[46] A. Kazlauskaite,et al. PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease , 2014, The FEBS journal.
[47] S. Gygi,et al. Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. , 2014, Molecular cell.
[48] P. Cortelli,et al. A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism. , 2014, Parkinsonism & related disorders.
[49] Kaya Bilgüvar,et al. FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family. , 2014, Parkinsonism & related disorders.
[50] Samuel Flores,et al. Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin , 2014, PLoS Comput. Biol..
[51] H. McBride,et al. A new pathway for mitochondrial quality control: mitochondrial‐derived vesicles , 2014, The EMBO journal.
[52] H. Juan,et al. FBXO7 Y52C Polymorphism as a Potential Protective Factor in Parkinson's Disease , 2014, PloS one.
[53] K. Chung,et al. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE) , 2014, Cellular and Molecular Life Sciences.
[54] T. Hirokawa,et al. Ubiquitin is phosphorylated by PINK1 to activate parkin , 2014, Nature.
[55] Soojay Banerjee,et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity , 2014, The Journal of cell biology.
[56] Christopher E. Berndsen,et al. New insights into ubiquitin E3 ligase mechanism , 2014, Nature Structural &Molecular Biology.
[57] K. Hofmann,et al. Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 , 2014, The Biochemical journal.
[58] Miratul M. K. Muqit,et al. Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity , 2014, Open Biology.
[59] H. Walden,et al. RBR E3 ubiquitin ligases: new structures, new insights, new questions , 2014, The Biochemical journal.
[60] Allison Craney,et al. Microtubule-dependent regulation of mitotic protein degradation. , 2014, Molecular cell.
[61] Patrick G. A. Pedrioli,et al. Phosphorylation of Parkin at Serine 65 is essential for activation : elaboration of a Miro 1 substrate-based assay of Parkin E 3 ligase activity , 2014 .
[62] J Wade Harper,et al. Building and remodelling Cullin–RING E3 ubiquitin ligases , 2013, EMBO reports.
[63] H. Laman,et al. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins , 2013, Open Biology.
[64] K. Hofmann,et al. TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes , 2013, The EMBO journal.
[65] A. Burlingame,et al. A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1 , 2013, Cell.
[66] J. Hardy,et al. The Parkinson’s disease genes Fbxo7 and Parkin interact to mediate mitophagy , 2013, Nature Neuroscience.
[67] Kalle Gehring,et al. Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation , 2013, Science.
[68] T. Shaler,et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases , 2013, Nature Communications.
[69] P. Mercier,et al. A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease , 2013, Nature Communications.
[70] B. Schulman,et al. Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. , 2013, Structure.
[71] David Komander,et al. Structure of the human Parkin ligase domain in an autoinhibited state , 2013, The EMBO journal.
[72] R. Youle,et al. PINK1 is degraded through the N-end rule pathway , 2013, Autophagy.
[73] Steven P. Gygi,et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization , 2013, Nature.
[74] Zhijian J. Chen,et al. Regulation of NF-κB by ubiquitination. , 2013, Current opinion in immunology.
[75] H. Braak,et al. 100 years of Lewy pathology , 2013, Nature Reviews Neurology.
[76] G. Swarup,et al. Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17 , 2012, Journal of Cell Science.
[77] R. Youle,et al. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.
[78] Yanji Xu,et al. Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. , 2012, Journal of proteome research.
[79] R. Bernards,et al. Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling , 2012, Journal of cellular and molecular medicine.
[80] I. Dikic,et al. Selectivity of the ubiquitin‐binding modules , 2012, FEBS letters.
[81] T. Sixma,et al. The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension , 2012, The EMBO journal.
[82] K. Rittinger,et al. LUBAC synthesizes linear ubiquitin chains via a thioester intermediate , 2012, EMBO reports.
[83] M. Rapé,et al. The Ubiquitin Code , 2012, Annual review of biochemistry.
[84] Miratul M. K. Muqit,et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.
[85] H. Walden,et al. Regulation of Parkin E3 ubiquitin ligase activity , 2012, Cellular and Molecular Life Sciences.
[86] R. Youle,et al. Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. , 2012, Developmental cell.
[87] P. Lockhart,et al. Parkinson’s Disease and Parkin: Insights from Park2 Knockout Mice , 2012 .
[88] J. Dushanova. Mechanisms in Parkinson's Disease - Models and Treatments , 2012 .
[89] A. Goldberg,et al. Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway , 2011, Proceedings of the National Academy of Sciences.
[90] Y. Liou,et al. HURP Regulates Chromosome Congression by Modulating Kinesin Kif18A Function , 2011, Current Biology.
[91] H. Walden,et al. Autoregulation of Parkin activity through its ubiquitin‐like domain , 2011, The EMBO journal.
[92] H. Laman,et al. Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells , 2011, Development.
[93] H. Laman,et al. Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells , 2011, Journal of Cell Science.
[94] S. Berger,et al. A genetic and molecular toolbox for analyzing histone ubiquitylation and sumoylation in yeast. , 2011, Methods.
[95] Rachel E. Klevit,et al. UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids , 2011, Nature.
[96] H. Laman,et al. A Competitive Binding Mechanism between Skp1 and Exportin 1 (CRM1) Controls the Localization of a Subset of F-box Proteins* , 2011, The Journal of Biological Chemistry.
[97] B. Oostra,et al. Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15) , 2011, PloS one.
[98] Sonja Hess,et al. Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy , 2011, Human molecular genetics.
[99] N. Zheng,et al. Structural assembly of cullin-RING ubiquitin ligase complexes. , 2010, Current opinion in structural biology.
[100] H. Houlden,et al. Common pathogenic pathways in melanoma and Parkinson disease , 2010, Neurology.
[101] A. Pisani,et al. Faculty Opinions recommendation of PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010 .
[102] Marc Cruts,et al. Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.
[103] N. Hattori,et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.
[104] P. Pástor,et al. PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.
[105] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[106] Atsushi Tanaka,et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.
[107] T. Dawson,et al. The role of parkin in familial and sporadic Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[108] Ted M. Dawson,et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.
[109] N. Jana,et al. The ubiquitin ligase E6‐AP promotes degradation of α‐synuclein , 2009, Journal of neurochemistry.
[110] V. Hristova,et al. Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin* , 2009, Journal of Biological Chemistry.
[111] B. Monsarrat,et al. Affinity Purification Strategy to Capture Human Endogenous Proteasome Complexes Diversity and to Identify Proteasome-interacting Proteins*S , 2009, Molecular & Cellular Proteomics.
[112] W. Oyen,et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.
[113] James Lowe,et al. Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.
[114] J. Murray-Rust,et al. Structure of a Conserved Dimerization Domain within the F-box Protein Fbxo7 and the PI31 Proteasome Inhibitor* , 2008, Journal of Biological Chemistry.
[115] B. Hyman,et al. CHIP Targets Toxic α-Synuclein Oligomers for Degradation* , 2008, Journal of Biological Chemistry.
[116] M. Ronaghi,et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.
[117] S. Lindquist,et al. The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.
[118] S. Lindquist,et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.
[119] A. Dürr,et al. Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1. , 2006, Archives of neurology.
[120] J. Kordower,et al. Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys , 2006, Annals of neurology.
[121] Li-Kwan Chang,et al. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination. , 2006, Biochemical and biophysical research communications.
[122] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[123] S. Henderson,et al. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6 , 2005, The EMBO journal.
[124] Hongjun Song,et al. Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death , 2005, The Journal of Neuroscience.
[125] S. Henderson,et al. Transforming activity of Fbxo 7 is mediated specifically through regulation of cyclin D / cdk 6 , 2005 .
[126] Chi-Ying F. Huang,et al. Fbx7 Functions in the SCF Complex Regulating Cdk1-Cyclin B-phosphorylated Hepatoma Up-regulated Protein (HURP) Proteolysis by a Proline-rich Region*[boxs] , 2004, Journal of Biological Chemistry.
[127] D. Perl,et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease , 2004, Annals of neurology.
[128] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[129] C. Ross,et al. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[130] C. Warren Olanow,et al. Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.
[131] Chi-Ying F. Huang,et al. Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma , 2003, Oncogene.
[132] P. Kloetzel,et al. PI31 is a modulator of proteasome formation and antigen processing , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[133] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[134] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[135] P. Kloetzel,et al. The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes , 1999, FEBS letters.
[136] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[137] A. Ciechanover,et al. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. , 1983, The Journal of biological chemistry.
[138] A. Hershko,et al. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. , 1978, Biochemical and biophysical research communications.
[139] G Goldstein,et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[140] Olive Lloyd-Baker. IDENTIFICATION OF NOVEL , 1964 .
[141] Nicholas W Wood,et al. The Parkinson ’ s disease – linked proteins Fbxo 7 and Parkin interact to mediate mitophagy , 2022 .